Literature DB >> 24449637

High-throughput miniaturized bioreactors for cell culture process development: reproducibility, scalability, and control.

Shahid Rameez1, Sigma S Mostafa, Christopher Miller, Abhinav A Shukla.   

Abstract

Decreasing the timeframe for cell culture process development has been a key goal toward accelerating biopharmaceutical development. Advanced Microscale Bioreactors (ambr™) is an automated micro-bioreactor system with miniature single-use bioreactors with a 10-15 mL working volume controlled by an automated workstation. This system was compared to conventional bioreactor systems in terms of its performance for the production of a monoclonal antibody in a recombinant Chinese Hamster Ovary cell line. The miniaturized bioreactor system was found to produce cell culture profiles that matched across scales to 3 L, 15 L, and 200 L stirred tank bioreactors. The processes used in this article involve complex feed formulations, perturbations, and strict process control within the design space, which are in-line with processes used for commercial scale manufacturing of biopharmaceuticals. Changes to important process parameters in ambr™ resulted in predictable cell growth, viability and titer changes, which were in good agreement to data from the conventional larger scale bioreactors. ambr™ was found to successfully reproduce variations in temperature, dissolved oxygen (DO), and pH conditions similar to the larger bioreactor systems. Additionally, the miniature bioreactors were found to react well to perturbations in pH and DO through adjustments to the Proportional and Integral control loop. The data presented here demonstrates the utility of the ambr™ system as a high throughput system for cell culture process development.
© 2014 American Institute of Chemical Engineers.

Entities:  

Keywords:  cell culture; high throughput; miniaturized bioreactors; monoclonal antibody

Mesh:

Substances:

Year:  2014        PMID: 24449637     DOI: 10.1002/btpr.1874

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  11 in total

Review 1.  The therapeutic monoclonal antibody market.

Authors:  Dawn M Ecker; Susan Dana Jones; Howard L Levine
Journal:  MAbs       Date:  2015       Impact factor: 5.857

2.  An anti-apoptotic HEK293 cell line provides a robust and high titer platform for transient protein expression in bioreactors.

Authors:  Tia A Arena; Bernice Chou; Peter D Harms; Athena W Wong
Journal:  MAbs       Date:  2019-04-24       Impact factor: 5.857

3.  Antibody Conjugate Assembly on Ultrasound-Confined Microcarrier Particles.

Authors:  Michael M Binkley; Mingyang Cui; Mikhail Y Berezin; J Mark Meacham
Journal:  ACS Biomater Sci Eng       Date:  2020-10-09

4.  Potential of Integrating Model-Based Design of Experiments Approaches and Process Analytical Technologies for Bioprocess Scale-Down.

Authors:  Peter Neubauer; Emmanuel Anane; Stefan Junne; Mariano Nicolas Cruz Bournazou
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

5.  Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8b.

Authors:  Diying Shen; Yongmin Tang; Sisi Li; Weiqun Xu; Lingyan Zhang
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-08

Review 6.  Bioengineering Outlook on Cultivated Meat Production.

Authors:  Ivana Pajčin; Teodora Knežić; Ivana Savic Azoulay; Vanja Vlajkov; Mila Djisalov; Ljiljana Janjušević; Jovana Grahovac; Ivana Gadjanski
Journal:  Micromachines (Basel)       Date:  2022-02-28       Impact factor: 2.891

7.  High throughput automated microbial bioreactor system used for clone selection and rapid scale-down process optimization.

Authors:  M Lourdes Velez-Suberbie; John P J Betts; Kelly L Walker; Colin Robinson; Barney Zoro; Eli Keshavarz-Moore
Journal:  Biotechnol Prog       Date:  2017-08-10

8.  Advanced multivariate data analysis to determine the root cause of trisulfide bond formation in a novel antibody-peptide fusion.

Authors:  Stephen Goldrick; William Holmes; Nicholas J Bond; Gareth Lewis; Marcel Kuiper; Richard Turner; Suzanne S Farid
Journal:  Biotechnol Bioeng       Date:  2017-06-05       Impact factor: 4.530

9.  Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells.

Authors:  Sai Rashmika Velugula-Yellela; Casey Kohnhorst; David N Powers; Nicholas Trunfio; Anneliese Faustino; Phillip Angart; Erica Berilla; Talia Faison; Cyrus Agarabi
Journal:  J Vis Exp       Date:  2018-09-28       Impact factor: 1.355

Review 10.  Conceptual Design of Micro-Bioreactors and Organ-on-Chips for Studies of Cell Cultures.

Authors:  Carl-Fredrik Mandenius
Journal:  Bioengineering (Basel)       Date:  2018-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.